Pegylated Interferon Alfa-2a from Canada
Pegylated recombinant interferon alfa-2a for chronic hepatitis C treatment, extending half-life for weekly dosing. An immunological product under HTS 3002.90.52.50 for therapeutic immune modulation. Biotechnologically modified cytokine.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Pegylation chemistry and activity data required
• Light-protected shipping for peg-interferon